Paclitaxel-Fe3O4 nanoparticles inhibit growth of CD138– CD34– tumor stem-like cells in multiple myeloma-bearing mice
Cuiping Yang,1,3,* Jing Wang,2,* Dengyu Chen,1,* Junsong Chen,1 Fei Xiong,4 Hongyi Zhang,1 Yunxia Zhang,2 Ning Gu,4 Jun Dou11Department of Pathogenic Biology and Immunology, Medical School, 2Department of Gynecology and Obstetrics, Zhongda Hospital, Southeast University, Nanjing, 3Departmen...
Guardado en:
Autores principales: | Yang C, Wang J, Chen D, Chen J, Xiong F, Zhang H, Zhang Y, Gu N, Dou J |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/318e3fe5089b4e0980e9635dff287020 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Phenotypic, genomic and functional characterization reveals no differences between CD138++ and CD138low subpopulations in multiple myeloma cell lines.
por: Teresa Paíno, et al.
Publicado: (2014) -
Transient loading of CD34+ hematopoietic progenitor cells with polystyrene nanoparticles
por: Deville S, et al.
Publicado: (2017) -
CD10 and CD138 can be expressed in giant cell tumor of bone: An immunohistochemical study
por: Mousa A Al-Abbadi, et al.
Publicado: (2016) -
MicroRNA-138 suppresses glioblastoma proliferation through downregulation of CD44
por: Margaret Yeh, et al.
Publicado: (2021) -
New developments in the treatment of multiple myeloma – clinical utility of daratumumab
por: McEllistrim C, et al.
Publicado: (2017)